BioAssay Plus
Chicago, United States· Est.
Specialized provider of recombinant protein, antibody, and rapid diagnostic reagents for infectious disease detection.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Specialized provider of recombinant protein, antibody, and rapid diagnostic reagents for infectious disease detection.
Infectious Diseases
Technology Platform
Proprietary recombinant protein expression combined with advanced antibody engineering and immunoassay development, enabling high‑specificity reagents and rapid lateral‑flow diagnostic devices.
Opportunities
Expansion into point‑of‑care markets and partnerships with public health agencies for outbreak response could drive growth.
Risk Factors
Regulatory hurdles, intense competition from larger diagnostics firms, and the need for continuous innovation pose significant risks.
Competitive Landscape
Competes with both large diagnostic manufacturers and specialized biotech service providers; differentiation lies in rapid custom reagent development and niche infectious disease focus.